SOLIGENIX, INC.
For the period ended Dec 31, 2024. Filed Mar 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 21, 2025
SNGX$0.34+0.5%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| | |
|---|---|
| | Page |
| Consolidated Balance Sheets as of December 31, 2024 and 2023 | F-2 |
| Consolidated Statements of Operations for the Years Ended December 31, 2024 and 2023 | F-3 |
| Consolidated Statements of Comprehensive Loss for the Years Ended December 31, 2024 and 2023 | F-4 |
| Consolidated Statements of Changes in Equity and Shareholders’ Equity (Deficit) for the Years Ended December 31, 2024 and 2023 | F-5 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2024 and 2023 | F-6 |
| Notes to Consolidated Financial Statements | F-7 – F-26 |
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 00677) | F-27 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.